共 15 条
- [1] Weinreb NJ(2004)Gaucher disease type 1: revised recommendations on evaluations and monitoring for adult patients Semin. Hematol. 41 15-22
- [2] Cox TM(2015)Innovative treatments for lysosomal diseases Best Pract. Res. Clin. Endocrinol. Metab. 29 275-311
- [3] Burton BK(2015)A phase 3 trial of sebelipase alfa in lysosomal acid lipase deficiency N. Engl. J. Med. 373 1010-1020
- [4] Bernstein DL(2013)Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease J. Hepatol. 58 1230-1243
- [5] Hülkova H(2012)Distinctive histopathological features that support a diagnosis of cholesterol ester storage disease in liver biopsy specimens Histopathology 60 1107-1113
- [6] Bialer MG(2011)Limitations of drug registries to evaluate orphan medicinal products for the treatment of lysosomal storage disorders Orphanet J. Rare Dis. 6 16-2914
- [7] Desnick RJ(2013)Exome sequencing and directed clinical phenotyping diagnose cholesterol ester storage disease presenting as autosomal recessive hypercholesterolemia Arterioscler. Thromb. Vasc. Biol. 33 2909-1073
- [8] Hulková H(2015)Lysosomal acid lipase deficiency—a new therapy for a genetic lipid disease N. Engl. J. Med. 373 1071-undefined
- [9] Elleder M(undefined)undefined undefined undefined undefined-undefined
- [10] Hollak CE(undefined)undefined undefined undefined undefined-undefined